Overactivation of PERK signalling is a feature of post-mortem brains of patients with Alzheimer's and Parkinson's diseases and the tauopathies, frontotemporal dementia (FTD) and Progressive Supranuclear Palsy (reviewed in Scheper and Hoozemans2). This evidence concerns the gene EIF2AK3 and frontotemporal dementia.